No opportunity to stretch the truth was missed by public figures.
The administration has ambitious enrollment goals, but needs to retain current participants.
It is bad enough when an agency spends taxpayer money foolishly; even worse when those expenditures undermine conclusions of another agency.
It makes people think about what's worth spending money on and what isn't.
GOP members of Congress should deal transparently with their health insurance subsidies.
Let us focus on a larger reality: Professor Gruber practices rather poor economics.
The FDA needs to complete its approval process for generic versions of biologic drugs.
Everything with politics today seems to be black or white, red or blue. But there's at least one issue that falls in between.
It is time to refute all the arguments against active dying.
A program identifying Medicare billing errors, overpayments and underpayments is under attack.